Efficacy and Safety of MAA868 in Patients With Atrial Fibrillation
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Prevention of Thromboembolic Events in Total Knee Replacement Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
Patient Reported Outcomes inVestigation Following Initiation of Drug Therapy With Entresto (Sacubitril/Valsartan) in Heart Failure
- Status
- COMPLETED
- Phase
- N/A
Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD
- Status
- COMPLETED
- Phase
- PHASE3
Study to Assess the Safety and Efficacy of Midostaurin (PKC412) in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Maintenance Monotherapy in Patients With Newly-diagnosed FMS-like Tyrosine 3 (FLT3) Kinase Receptor-mutated Acute Myeloid Leukemia.
- Status
- COMPLETED
- Phase
- PHASE3
A Randomized Study to Evaluate the Effect of Reminder Notifications and Motivational/Adaptive Messaging on Treatment Adherence
- Status
- TERMINATED
- Phase
- PHASE3
LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Urinary Tract Infection (cUTI)
- Status
- WITHDRAWN
- Phase
- PHASE2
A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Crushed Deferasirox Film Coated Tablets in Pediatric Patients With Transfusional Hemosiderosis
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate CSJ148 in Pregnant Women With Primary HCMV Infection
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients
- Status
- COMPLETED
- Phase
- PHASE3
PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
First-in-human, Safety, Tolerability and Pharmacokinetics Study of LRX712 in Osteoarthritic Patients
- Status
- COMPLETED
- Phase
- PHASE1
LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI)
- Status
- TERMINATED
- Phase
- PHASE2
Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE4
Development of Novel Clinical Endpoints in Intermediate AMD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study of Efficacy, Safety and Tolerability of AIN457 in Patients With Active Overuse Tendinopathy
- Status
- COMPLETED
- Phase
- PHASE2
Dabrafenib and/or Trametinib Rollover Study
- Status
- RECRUITING
- Phase
- PHASE4
Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH).
- Status
- COMPLETED
- Phase
- PHASE2